Symbol: |
IER5L
|
Description: |
immediate early response 5-like [Source:HGNC Symbol;Acc:23679]
|
Location: |
Chr9:131937835-131940540[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:250
Gene |
Compound |
Gen_sig |
Exp_pattern |
IER5L |
NSC 699933 |
0.038 |
Up |
IER5L |
NSC 700436 |
0.003 |
Up |
IER5L |
NSC 701639 |
0.026 |
Up |
IER5L |
NSC 703027 |
0.027 |
Up |
IER5L |
NSC 703315 |
0.017 |
Up |
IER5L |
NSC 703439 |
0.001 |
Up |
IER5L |
NSC 704212 |
0.018 |
Down |
IER5L |
NSC 704281 |
0.001 |
Up |
IER5L |
NSC 704286 |
0.005 |
Up |
IER5L |
NSC 704556 |
0.001 |
Up |
IER5L |
NSC 704598 |
0.001 |
Down |
IER5L |
NSC 704618 |
0.021 |
Down |
IER5L |
2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- |
0.001 |
Up |
IER5L |
3-Iodoacetamido-benzoylurea |
0.016 |
Up |
IER5L |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.029 |
Up |
Expression pattern: Sensitivity / Resistance
Total:17 Current:12
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:25
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:25
Total:2 Current:1
[First] [Prev]  Next Last 
|